Efficacy of Methylene Blue Mediated Photodynamic Therapy for Primary Localized Cutaneous Amyloidosis Treatment in Asians

Chulalongkorn University

Status: Unknown

Conditions: Lichen Amyloidosis

Treatments: Procedure: Methylene blue-mediated photodynamic therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT03068208

CU_MBPDT_for_amyloidosis

Details and patient eligibility

About

Efficacy of Methylene blue mediated Photodynamic therapy for primary localized cutaneous amyloidosis treatment in Asians, pilot study.

Enrollment: 15 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients, aged > 18 years old with lichen amyloidosis diagnosed by using clinical presentation and pathological findings.

Exclusion criteria

• Those with systemic disease associated cutaneous amyloidosis
• Pregnancy or lactating woman
• Those who are allergic to urea, olive oil
• Those who are photosensitive to ultraviolet radiation
• Those who had been previously treated with any of which -medications, radiation, laser within 3 months and 1 month for topical therapy

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

15 participants in 2 patient groups

MB-PDT

Experimental group

Treatment:

Procedure: Methylene blue-mediated photodynamic therapy

Control

No Intervention group